STOCK TITAN

AbCellera to Report Full Year 2021 Financial Results on February 24, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

AbCellera (Nasdaq: ABCL) will report its full year 2021 financial results on February 24, 2022, after market close. The earnings conference call will commence at 2:00 p.m. PT (5:00 p.m. ET), with a live webcast available on AbCellera’s Investor Relations website. The company specializes in antibody development, partnering with various drug developers to enhance drug development efficiency.

Positive
  • Upcoming earnings report may provide insights into financial performance and growth.
  • The company partners with both large and small drug developers, showcasing a broad market appeal.
Negative
  • None.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) announced today that it will report full year 2021 financial results after market close on Thursday, February 24, 2022 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

The live webcast of the earnings conference will be available through a link that will be posted on AbCellera’s Investor Relations website. A replay of the webcast will be available through the same link following the conference call.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, visit www.abcellera.com.

Source: AbCellera Biologics Inc.

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116

Source: AbCellera

FAQ

When will AbCellera report its 2021 financial results?

AbCellera will report its financial results on February 24, 2022, after market close.

What time is AbCellera's earnings conference call?

The earnings conference call will be held at 2:00 p.m. Pacific Time on February 24, 2022.

Where can I access the webcast for AbCellera's earnings call?

The live webcast will be available on AbCellera’s Investor Relations website.

What is AbCellera's business focus?

AbCellera focuses on searching and analyzing natural immune systems to discover antibodies for drug development.

AbCellera Biologics Inc. Common Shares

NASDAQ:ABCL

ABCL Rankings

ABCL Latest News

ABCL Stock Data

827.03M
208.65M
27.93%
39.78%
5.39%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
VANCOUVER